Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single high-dose ATG-Fresenius induction in renal transplant recipients from non-heart-beating donors
2007-000210-36Phase 3Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of antithymocyte globulin rabbit in delayed graft function (DGF) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Incidence of initial delayed graft function. Started Aug 2007; status: terminated.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on 2007-000210-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000210-36.